10-Q: Target Group Reports Wider Losses, Revenue Decline

Target Group Inc. reported a significant increase in net loss and a decline in revenue for the nine months ended September 30, 2025, raising substantial doubt about its ability to continue as a going concern.

Summary

• Net loss for the nine months ended September 30, 2025, significantly widened to $807,375, compared to a net loss of $55,454 for the same period in 2024.
• Revenue decreased to $3,145,813 for the nine months ended September 30, 2025, from $4,736,055 in the prior year period.
• The company reported a working capital deficit of $10,558,219 as of September 30, 2025, an increase from $9,994,548 at December 31, 2024.
• Cash and restricted cash decreased substantially to $345,748 as of September 30, 2025, from $1,877,759 at the beginning of the period.
• Operating activities used $591,637 in cash for the nine months ended September 30, 2025, a significant negative shift from providing $1,426,247 in the prior year.
• The company's disclosure controls and procedures were deemed not effective as of September 30, 2025.
• Total liabilities stood at $13,630,641 as of September 30, 2025, with a significant portion ($10,198,072) owed to related parties.

Sentiment

Score: 2

Explanation: The company faces severe financial distress, evidenced by widening losses, declining revenue, a substantial working capital deficit, and a 'going concern' warning. While management is seeking new opportunities and financing, the current financial performance and control deficiencies are highly concerning.

Positives

• Management is exploring new opportunities at its Simcoe, Ontario cultivation facility to expand product offerings in other cannabis-related consumer packaged goods (CPG) categories.
• The Eleventh Amending Agreement extended the maturity date of the shareholder loan from Jerry Zarcone to August 31, 2026, providing some short-term debt relief.
• The company's subsidiary, Canary, holds licenses to cultivate, process, and sell cannabis and has a strategic partnership with Serious Seeds B.V. for proprietary genetics.
• 10,150,003 warrants expired during the nine months ended September 30, 2025, reducing potential future dilution from these specific warrants.

Negatives

• Net loss increased significantly to $807,375 for the nine months ended September 30, 2025, from $55,454 in the prior year.
• Revenue declined by approximately 33.6% to $3,145,813 for the nine months ended September 30, 2025, compared to $4,736,055 in the same period of 2024.
• Cash and restricted cash balances plummeted from $1,877,759 at the beginning of the period to $345,748 as of September 30, 2025.
• The working capital deficit worsened to $10,558,219 from $9,994,548 at December 31, 2024.
• The accumulated deficit grew to $31,754,219 as of September 30, 2025.
• Operating activities consumed cash, a reversal from the prior year's cash generation.
• Disclosure controls and procedures were found to be ineffective.
• CannaKorp's patents are unmaintained due to missed annuity payments, and management is still determining their value.
• The entire outstanding balance of the related party loan from CL Investors Inc. ($7,486,502) has been reclassified to current liabilities, indicating immediate repayment pressure.

Risks

• Substantial doubt exists about the company's ability to continue as a going concern due to recurring operating losses and a significant working capital deficit.
• The company's continuation is dependent on generating sufficient cash flows from operations or obtaining additional financing.
• Failure to acquire additional working capital will necessitate a significant reduction in current operations.
• The company faces several legal proceedings, including a $1,492,250 lawsuit from a terminated employee, a $150,000 complaint from a former CFO, and a $92,930 claim from a vendor.
• CannaKorp's patents are unmaintained due to missed annuity payments, potentially jeopardizing intellectual property.
• The entire outstanding balance of the CL Investors Inc. loan ($7,486,502) has been reclassified to current liabilities, and the company is in discussions to revise terms, indicating potential default or renegotiation risk.
• The company relies heavily on related party debt financing, which can introduce conflicts of interest and dependency risks.
• Issuance of additional common stock to raise capital could dilute current shareholders' value.

Future Outlook

The company is exploring new opportunities at its Simcoe, Ontario cultivation facility to expand product offerings in other cannabis-related consumer packaged goods (CPG) categories. It anticipates that future operations will generate positive cash flows, provided it successfully obtains additional financing in the foreseeable future. CannaKorp is actively seeking a joint venture partner and/or a licensor to assist in marketing and launching the Wisp Vaporizer and Wisp Pods in both the US and Canadian legal cannabis or hemp markets.

Management Comments

• "Our disclosure controls and procedures were not effective as of September 30, 2025."
• "The Company is actively seeking various financing opportunities to meet the deficit capital requirements."
• "If the Company is unable to acquire additional working capital, it will be required to significantly reduce its current level of operations."
• "Management is determining the value maintaining these patents will provide the Company."
• "The management is of the view that no material losses will arise in respect of the legal claim at the date of this report."

Industry Context

The company operates in the Canadian cannabis market, which legalized adult-use cannabis in October 2018. Deloitte projected the Canadian adult-use market to range from CDN$1.8 billion to CDN$4.3 billion in 2019 and the medical cannabis market to reach CDN$1.3 billion annually by 2024. Target Group aims to position itself with a core emphasis on wholesale and co-packaging services, integrating cannabinoid research, analytical testing, product development, and manufacturing. The industry is characterized by heavy regulation and a shift in public perception towards legalization globally.

Comparison to Industry Standards

• The company's significant revenue decline and widening net losses contrast sharply with the overall growth trajectory expected in the Canadian cannabis market, which Health Canada projected to reach CDN$1.3 billion in annual value by 2024.
• The substantial working capital deficit and reliance on related-party debt suggest a weaker financial position compared to more established or better-capitalized industry players.
• The ineffectiveness of disclosure controls and procedures indicates a governance weakness that is below standard for publicly traded companies, regardless of industry.
• The unmaintained patents for CannaKorp's vaporizer technology suggest a failure to protect key intellectual property, which is critical for innovation-driven companies in the cannabis sector.

Management Changes

Corporate Governance

Legal Proceedings

• Lawsuit by a terminated Canary employee for approximately $1,492,250 (CAD $2,100,000) in Ontario, Canada. The company is defending its position.
• Complaint for damages of $150,000 against CannaKorp by its former Chief Financial Officer for outstanding professional fees. No claim has been registered, and management believes no material losses will arise.
• Claim for damages of approximately $92,930 (CAD $130,778) against Canary by a vendor for breach of contract. Management believes no material losses will arise.

Related Party Transactions

• Outstanding balance of $3,592 (CAD $5,000) from CL Investors Inc. (CLI), a related party where the CEO is a shareholder and Secretary, and his brother is President and sole director.
• Interest expense of $283,660 (CAD $396,635) charged for the nine months ended September 30, 2025, from CLI.
• Accrued interest of $717,344 (CAD 998,669) to CLI included in accounts payable.
• The entire outstanding balance of the CLI loan ($7,486,502) has been reclassified to current liabilities, with discussions ongoing to revise terms.
• Shareholder loan from Jerry Zarcone (a company shareholder) with an outstanding balance of $2,064,151 (CAD $2,786,380), secured by all company assets and maturing on August 31, 2026.
• Interest expense of $492,597 (CAD $688,786) charged for the nine months ended September 30, 2025, from the shareholder loan.
• Outstanding management service fee of $644,947 owed to key officers of the company.
• Outstanding balance of $65,000 to a former CannaKorp shareholder as part of a settlement agreement, including $25,000 in late payment penalties.
• Outstanding balance of $24,350 for consulting services from GTA Angel Group, owned by the CEO's brother.

Stakeholder Impact

• Shareholders face significant dilution risk from potential future capital raises, negative impact from widening losses and declining revenue, and uncertainty due to the "going concern" warning. Ineffective disclosure controls also pose a governance risk.
• Creditors (Related Parties) face immediate repayment pressure due to the reclassification of the CLI loan to current liabilities, potentially impacting the company's ability to meet other obligations. The extension of the shareholder loan provides some flexibility but highlights ongoing reliance.
• Employees may face potential operational reductions if financing is not secured, which could impact employment due to the "going concern" warning and need for additional capital.
• Customers may experience reduced product availability or changes in service due to declining revenue and potential operational cutbacks.
• Suppliers may face payment delays or strained relationships given the company's financial distress and significant accounts payable.

Next Steps

• Management will continue to explore new opportunities at its Simcoe, Ontario cultivation facility to expand product offerings.
• The company will continue to seek additional financing to meet capital requirements and support operations.
• Management is assessing the value of maintaining CannaKorp's unmaintained patents.
• CannaKorp is actively seeking a joint venture partner and/or licensor for its Wisp Vaporizer and Wisp Pods.
• The company is under discussions to formalize arrangements with the lender to revise the terms of the CL Investors Inc. loan.

Key Dates

Recommendation

The company is in a precarious financial position, marked by a substantial decline in revenue, a significant increase in net losses, and a severe working capital deficit. The explicit "going concern" warning, coupled with ineffective disclosure controls and a heavy reliance on related-party debt, signals high operational and financial risk. The reclassification of a major related-party loan to current liabilities indicates immediate liquidity pressure. While management is seeking new opportunities and financing, the current trajectory suggests a high probability of further value erosion and potential insolvency without substantial, immediate, and successful intervention.

Keywords

Cannabis, Marijuana, Cultivation, Processing, Distribution, Canada, SEC Filing, 10-Q, Financial Results, Going Concern, Canary Rx, Serious Seeds, Intellectual Property, Related Party Debt